{"id":3137,"date":"2017-10-13T09:48:27","date_gmt":"2017-10-13T13:48:27","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3137"},"modified":"2017-10-13T17:40:06","modified_gmt":"2017-10-13T21:40:06","slug":"ipo-pipeline-10-6-17-10-13-17-filings-terms-continue-to-flow-in","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-10-6-17-10-13-17-filings-terms-continue-to-flow-in\/","title":{"rendered":"IPO Pipeline (10.6.17 &#8211; 10.13.17) &#8211; Filings &#038; Terms continue to flow in"},"content":{"rendered":"<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/09\/Screen-Shot-2017-09-22-at-9.34.24-AM.png\"><br \/>\n<\/a>IPO Boutique keeps apprised of the active pipeline. Currently there are 78 active IPOs in the pipeline as of October 13, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=2877\" target=\"_blank\"><strong>in this article.<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-13-at-9.47.58-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-3140\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-13-at-9.47.58-AM.png\" alt=\"Pipeline101317\" width=\"657\" height=\"406\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-13-at-9.47.58-AM.png 657w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-13-at-9.47.58-AM-600x371.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-13-at-9.47.58-AM-300x185.png 300w\" sizes=\"(max-width: 657px) 100vw, 657px\" \/><\/a><\/p>\n<p dir=\"ltr\"><strong><u>NEW FILINGS<\/u><\/strong><\/p>\n<p dir=\"ltr\">Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Funko, Inc<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0FNKO<br \/>\nDescription: \u00a0\u00a0\u00a0\u00a0They are a leading pop culture consumer products company.<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<br \/>\nUnderwriter(s): \u00a0Goldman Sachs &amp; Co., J.P. Morgan, BofA Merrill Lynch<br \/>\nCo-Manager(s): Piper Jaffray, Jefferies, Stifel, BMO Capital Markets, SunTrust Robinson Humphrey<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1704711\/000119312517305846\/d369769ds1.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1704711\/000119312517305846\/d369769ds1.htm\">Filed 10-06-17<\/a><br \/>\nListed Cash Raise: $100 million<\/p>\n<p dir=\"ltr\">Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Allena Pharmaceuticals, Inc.<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0ALNA<br \/>\nDescription: \u00a0\u00a0\u00a0\u00a0They are a late-stage clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<br \/>\nUnderwriter(s): \u00a0Credit Suisse, Jefferies, Cowen &amp; Company<br \/>\nCo-Manager(s): Wedbush PacGrow<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1624658\/000119312517305872\/d431688ds1.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1624658\/000119312517305872\/d431688ds1.htm\">Filed 10-06-17<br \/>\n<\/a>Listed Cash Raise: $92 million<\/p>\n<p dir=\"ltr\">Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Spero Therapeutics, Inc.<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0SPRO<br \/>\nDescription: \u00a0\u00a0\u00a0\u00a0They are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections.<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<br \/>\nUnderwriter(s): BofA Merrill Lynch, Cowen &amp; Company, Stifel<br \/>\nCo-Manager(s): Oppenheimer &amp; Co.<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1701108\/000119312517305888\/d431217ds1.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1701108\/000119312517305888\/d431217ds1.htm\">Filed 10-06-17<\/a><br \/>\nListed Cash Raise: $86.25 million<\/p>\n<p dir=\"ltr\">Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Aquantia Corp.<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0AQ<br \/>\nDescription: \u00a0\u00a0\u00a0\u00a0They are a leader in the design, development and marketing of advanced high-speed communications integrated circuits, or ICs, for Ethernet connectivity in the data center, enterprise infrastructure and access markets.<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<br \/>\nUnderwriter(s): Morgan Stanley, Barclays, Deutsche Bank Securities<br \/>\nCo-Manager(s): Needham &amp; Co., Raymond James<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1316016\/000119312517306042\/d106686ds1.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1316016\/000119312517306042\/d106686ds1.htm\">Filed 10-06-17<\/a><br \/>\nListed Cash Raise: $86.25 million<\/p>\n<p dir=\"ltr\">Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0ERYTECH Pharma S.A.<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0ERYP<br \/>\nDescription: \u00a0\u00a0\u00a0\u00a0They are a biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases. Their ordinary shares are listed on Euronext Paris under the symbol &#8216;ERYP&#8217;.<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<br \/>\nUnderwriter(s): Jefferies, Cowen, Oddo BHF<br \/>\nCo-Manager(s): JMP Securities<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1624422\/000119312517306022\/d373760df1.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1624422\/000119312517306022\/d373760df1.htm\">Filed 10-06-17<\/a><br \/>\nListed Cash Raise: $100 million<\/p>\n<p dir=\"ltr\">Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Sogou Inc<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0SOGO<br \/>\nDescription: \u00a0\u00a0\u00a0\u00a0They are an innovator in search and a leader in China&#8217;s Internet industry. Their Sogou Search is the second largest search engine by mobile queries in China and they are the fourth largest Internet company in China.<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<br \/>\nUnderwriter(s): J.P. Morgan, Credit Suisse, Goldman Sachs, CICC<br \/>\nCo-Manager(s): China Renaissance<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1713947\/000104746917006357\/a2233383zf-1.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1713947\/000104746917006357\/a2233383zf-1.htm\">Filed 10-13-17<\/a><br \/>\nListed Cash Raise: $600 million<\/p>\n<p>Company: Apellis Pharmaceuticals<br \/>\nSymbol: APLS<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Citigroup, J.P. Morgan<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $150 million<br \/>\nNote: Previously withdrawn in February 2016<\/p>\n<p>Company: CBTX, Inc<br \/>\nSymbol: CBTX<br \/>\nDescription: They are a bank holding company that operates through our wholly-owned subsidiary, CommunityBank of Texas, in Houston and Beaumont, Texas.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Stephens, Keefe Bruyette &amp; Woods, Sandler O&#8217; Neill + Partners<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $50 million<\/p>\n<p>Company: Bandwidth, Inc<br \/>\nSymbol: BAND<br \/>\nDescription: They are a leading cloud-based communications platform for enterprises in the United States.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Keybanc Capital, Baird<br \/>\nCo-Manager(s): Canaccord Genuity, JMP Securities<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $85 million<\/p>\n<p>Company: Four Seasons Education (Cayman) Inc.<br \/>\nSymbol: TBD<br \/>\nDescription: They are dedicataed to providing high quality math education. In 2016 and the six months ended June 30, 2017, we were the largest after-school math education service provider for elementary school students in Shanghai, as measured by gross billings and number of students, according to the Frost &amp; Sullivan Report.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Citigroup, China Renaissance<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $120 million<\/p>\n<p>Company: PPDAI Group Inc.<br \/>\nSymbol: PPDF<br \/>\nDescription: They are a leading online consumer finance marketplace in China with strong brand recognition.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Credit Suisse, Citigroup<br \/>\nCo-Manager(s): Keefe Bruyette &amp; Woods<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $350 million<\/p>\n<p>Company: Fireman B.V.<br \/>\nSymbol: IFRX<br \/>\nDescription: They are a clinical stage biopharmaceutical company focused on applying their proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Leerink Partners, BMO Capital Markets<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $86.25 million<\/p>\n<p dir=\"ltr\"><strong><u>Updated Terms<\/u><\/strong><\/p>\n<p dir=\"ltr\">Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0RISE Education Cayman Ltd.<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0REDU<br \/>\nDescription: \u00a0\u00a0\u00a0\u00a0They operate in Chinas junior English Language Training, or ELT, market, which refers to after-school English teaching and tutoring services provided by training institutions to students aged three\u00a0to 18.<br \/>\nShares: 11 million ADSs<br \/>\nPrice Range: $12.00-$14.00<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a010\/20<br \/>\nUnderwriter(s): \u00a0Morgan Stanley, Credit Suisse, UBS<br \/>\nCo-Manager(s): HSBC<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1712178\/000119312517305738\/d414107df1a.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1712178\/000119312517305738\/d414107df1a.htm\">Terms Added: 10-6-17<\/a><\/p>\n<p>Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Sea Limited<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0SE<br \/>\nDescription: \u00a0\u00a0\u00a0\u00a0They have developed an integrated platform consisting of digital entertainment (focused on online games), e-commerce, and digital financial services (focused on e-wallet services), each localized to meet the unique characteristics of GSEA. We define GSEA as the combined region of Indonesia, Taiwan, Vietnam, Thailand, the Philippines, Malaysia and Singapore.<br \/>\nShares: 49.69 million<br \/>\nRange: $12.00-$14.00<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a0TBD<br \/>\nUnderwriter(s): \u00a0Goldman Sachs (Asia), Morgan Stanley, Credit Suisse<br \/>\nCo-Manager(s): CITIC, CLSA, Citigroup, Cowen, Nomura, Piper Jaffray, Stifel, Mandiri Sekuritas, PWP Securities, BDO Capital &amp; Investment Corporation, Cathay Securities Corporation, DBS Bank Ltd., Viet Capital Securities<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1703399\/000119312517305902\/d363501df1a.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1703399\/000119312517305902\/d363501df1a.htm\">Terms Added: 10-6-17<\/a><\/p>\n<p dir=\"ltr\">Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0LiveXLive Media, Inc.<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0LIVX<br \/>\nDescription: \u00a0\u00a0They are one of the world\u2019s only premium internet networks devoted to live music and music-related video content.<br \/>\nShares: 7.69 million<br \/>\nPrice Range: $12.00-$14.00<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a010\/19<br \/>\nUnderwriter(s): \u00a0BMO Capital Markets<br \/>\nCo-Manager(s): JMP Securities, Craig Hallum Group<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1491419\/000121390017010383\/fs12017a3_livexlivemedia.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1491419\/000121390017010383\/fs12017a3_livexlivemedia.htm\">Terms Added: 10-6-17<\/a><\/p>\n<p>Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Loma Negra Corporation<br \/>\nSymbol: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0LOMA<br \/>\nDescription: \u00a0\u00a0\u00a0Loma Negra is the leading cement producer in Argentina.<br \/>\nShares: 50.2 million ADSs<br \/>\nPrice Range: $15.00-$19.00<br \/>\nTrade Date: \u00a0\u00a0\u00a0\u00a011\/1<br \/>\nUnderwriter(s): \u00a0BofA Merrill Lynch, Bradesco BBI, Citigroup, HSBC, Itau BBA, Morgan Stanley<br \/>\n<a href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1711375\/000119312517308793\/d225541df1a.htm\" data-cke-saved-href=\"https:\/\/www.sec.gov\/Archives\/edgar\/data\/1711375\/000119312517308793\/d225541df1a.htm\">Terms Added: 10-12-17<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 78 active IPOs in the pipeline as of October 13, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS Company: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Funko,[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-3137","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3137"}],"version-history":[{"count":4,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3137\/revisions"}],"predecessor-version":[{"id":3178,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3137\/revisions\/3178"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}